Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting
Stryker (NYSE: SYK) unveiled significant advancements in its Mako SmartRobotics™ technology at AAOS 2025 Annual Meeting in San Diego. The company highlighted that Mako has achieved over 1.5 million procedures globally across 45 countries.
Key announcements include:
- Introduction of Mako Total Hip with Advanced Primary and Revision, featuring first-to-market robotic hip revision capability
- Launch of fourth-generation Mako 4 system, offering multiple applications across Total Hip, Total Knee, Partial Knee and Spine procedures
- Integration of fourth-generation Q Guidance System
- Expansion into Mako Spine and Mako Shoulder applications
The company completed initial Mako Spine cases in October and plans full U.S. commercial launch in second half of 2025. Mako Shoulder, introduced late last year, remains in market release through 2025.
Stryker (NYSE: SYK) ha presentato importanti progressi nella sua tecnologia Mako SmartRobotics™ durante l'AAOS 2025 Annual Meeting a San Diego. L'azienda ha sottolineato che Mako ha raggiunto oltre 1,5 milioni di procedure a livello globale in 45 paesi.
Le principali novità includono:
- Introduzione del Mako Total Hip con Advanced Primary e Revision, che presenta la prima capacità di revisione dell'anca robotica sul mercato
- Lancio del sistema Mako 4 di quarta generazione, che offre molteplici applicazioni nelle procedure di Total Hip, Total Knee, Partial Knee e Spine
- Integrazione del sistema di guida Q di quarta generazione
- Espansione nelle applicazioni Mako Spine e Mako Shoulder
L'azienda ha completato i casi iniziali di Mako Spine a ottobre e prevede un lancio commerciale completo negli Stati Uniti nella seconda metà del 2025. Mako Shoulder, introdotto alla fine dello scorso anno, rimane in fase di rilascio sul mercato fino al 2025.
Stryker (NYSE: SYK) presentó avances significativos en su tecnología Mako SmartRobotics™ en la Reunión Anual AAOS 2025 en San Diego. La compañía destacó que Mako ha logrado más de 1.5 millones de procedimientos a nivel global en 45 países.
Los anuncios clave incluyen:
- Introducción de Mako Total Hip con Advanced Primary y Revision, que presenta la primera capacidad de revisión de cadera robótica en el mercado
- Lanzamiento del sistema Mako 4 de cuarta generación, que ofrece múltiples aplicaciones en procedimientos de Total Hip, Total Knee, Partial Knee y Spine
- Integración del sistema de guía Q de cuarta generación
- Expansión en aplicaciones de Mako Spine y Mako Shoulder
La compañía completó los casos iniciales de Mako Spine en octubre y planea un lanzamiento comercial completo en EE. UU. en la segunda mitad de 2025. Mako Shoulder, introducido a finales del año pasado, seguirá en lanzamiento al mercado hasta 2025.
스트라이커 (NYSE: SYK)는 샌디에이고에서 열린 AAOS 2025 연례 회의에서 Mako SmartRobotics™ 기술의 중요한 발전을 발표했습니다. 이 회사는 Mako가 45개국에서 전 세계적으로 150만 건 이상의 수술을 수행했다고 강조했습니다.
주요 발표 내용은 다음과 같습니다:
- 시장 최초의 로봇 고관절 재수술 기능을 갖춘 Advanced Primary 및 Revision이 포함된 Mako Total Hip의 도입
- Total Hip, Total Knee, Partial Knee 및 Spine 절차 전반에 걸쳐 여러 응용 프로그램을 제공하는 4세대 Mako 4 시스템 출시
- 4세대 Q Guidance System의 통합
- Mako Spine 및 Mako Shoulder 응용 프로그램으로의 확장
회사는 10월에 초기 Mako Spine 사례를 완료했으며, 2025년 하반기에 미국에서의 상업적 출시를 계획하고 있습니다. 지난해 말에 도입된 Mako Shoulder는 2025년까지 시장 출시가 진행 중입니다.
Stryker (NYSE: SYK) a dévoilé des avancées significatives dans sa technologie Mako SmartRobotics™ lors de la réunion annuelle AAOS 2025 à San Diego. L'entreprise a souligné que Mako a réalisé plus de 1,5 million de procédures dans le monde entier dans 45 pays.
Les annonces clés comprennent:
- Introduction de Mako Total Hip avec Advanced Primary et Revision, présentant la première capacité de révision de hanche robotique sur le marché
- Lancement du système Mako 4 de quatrième génération, offrant plusieurs applications dans les procédures de Total Hip, Total Knee, Partial Knee et Spine
- Intégration du système de guidage Q de quatrième génération
- Expansion dans les applications Mako Spine et Mako Shoulder
L'entreprise a terminé les premiers cas de Mako Spine en octobre et prévoit un lancement commercial complet aux États-Unis dans la seconde moitié de 2025. Mako Shoulder, introduit à la fin de l'année dernière, reste en cours de lancement sur le marché jusqu'en 2025.
Stryker (NYSE: SYK) hat auf dem AAOS 2025 Annual Meeting in San Diego bedeutende Fortschritte in seiner Mako SmartRobotics™ Technologie vorgestellt. Das Unternehmen hob hervor, dass Mako weltweit über 1,5 Millionen Eingriffe in 45 Ländern durchgeführt hat.
Wichtige Ankündigungen umfassen:
- Einführung des Mako Total Hip mit Advanced Primary und Revision, das als erstes auf dem Markt die robotergestützte Hüftrevision ermöglicht
- Markteinführung des vierten Generation Mako 4 Systems, das mehrere Anwendungen in den Bereichen Total Hip, Total Knee, Partial Knee und Spine bietet
- Integration des vierten Generation Q Guidance Systems
- Erweiterung in die Mako Spine und Mako Shoulder Anwendungen
Das Unternehmen hat im Oktober die ersten Mako Spine Fälle abgeschlossen und plant eine vollständige kommerzielle Einführung in den USA in der zweiten Hälfte von 2025. Mako Shoulder, das Ende letzten Jahres eingeführt wurde, bleibt bis 2025 auf dem Markt.
- Market leadership with 1.5 million Mako procedures performed globally across 45 countries
- First-to-market position in robotic hip revision capability
- Expansion of product portfolio with Mako 4 system supporting multiple applications
- Strategic entry into new markets with Spine and Shoulder applications
- market release status for both Spine and Shoulder applications through 2025
- Delayed full commercial launch of Mako Spine until second half of 2025
Insights
Stryker's expansion of its Mako SmartRobotics platform represents a significant product advancement that strengthens the company's position in the high-growth robotic surgery market. The introduction of first-to-market robotic hip revision capability and the commercial launch of their fourth-generation Mako System demonstrates continued innovation in a core business segment. With over 1.5 million Mako procedures already performed globally across 45 countries, this platform expansion into spine and shoulder applications substantially increases Stryker's addressable market.
The phased commercialization strategy— market release transitioning to full commercial launch—is industry standard and reduces implementation risks while allowing for controlled market development. The timeline providing full U.S. commercial launch of Mako Spine in second half 2025 gives investors concrete expectations for this product line. Stryker's continued investment in expanding robotic applications across additional orthopedic specialties aligns with the broader industry trend toward minimally invasive, technology-enabled procedures that can command premium pricing in the medical device market.
While the announcement doesn't include financial projections, the expansion of capabilities into revision procedures and new anatomical applications should support continued system placements and procedural growth, potentially enhancing both capital equipment revenue and recurring procedure-specific revenue streams.
Latest technology offers more applications and innovation across more specialties
With the introduction of Mako Total Hip with Advanced Primary and Revision, Stryker expands on its established Mako Total Hip offering to include a first-to-market robotic hip revision capability. In revision total hip arthroplasty (THA), the expanded Mako Total Hip application is engineered to streamline workflow and enable confidence in challenging procedures with new features such as augment and screw planning, intraoperative screw trajectory guidance and compatibility with Stryker's revision hip implant portfolio. These new capabilities are designed to help surgeons simplify hip procedures by knowing more with Mako's 3D CT-based planning, now across both primary and revision THA procedures.
Additionally, now commercially available is Stryker's fourth generation Mako System, Mako 4, a single robotics system that delivers additional applications and innovation, designed to offer a premium clinical and operational experience compared to manual across Mako Total Hip, Total Knee, Partial Knee and Spine. Mako 4 also integrates Stryker's fourth-generation Q Guidance System, which is built on over 20 years of experience developing guidance technologies.
"Today's advancements in Mako SmartRobotics™ build on a foundation of clinical impact, innovation and market leadership," said Keith Evans, vice president and general manager of Stryker's Mako and Enabling Technologies business. "We are thrilled to showcase and demonstrate the future of Mako, not only what it can do but who it serves – more surgeons, more patients, across more specialties and more procedures."
Mako Spine and Mako Shoulder are the latest to join the SmartRobotics™ suite of applications. Stryker completed its first Mako Spine cases in October and continues its limited market release with full
AAOS 2025 Annual Meeting attendees can visit Stryker's booth (#2529) to learn more about Mako 4 and our new applications. Stryker will hold demonstrations, exhibitions and a symposium throughout the week. For more information, please visit – MakoMeansMore.com.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Media contact
Stryker, Joint Replacement
Niamh Grano
Sr. Communications Manager
niamh.grano@stryker.com
201.831.5589
View original content to download multimedia:https://www.prnewswire.com/news-releases/stryker-showcases-next-generation-of-mako-smartrobotics-at-aaos-2025-annual-meeting-302397425.html
SOURCE Stryker
FAQ
What new features does Stryker's Mako Total Hip with Advanced Primary and Revision offer?
How many Mako procedures has Stryker (SYK) performed globally?
When will Stryker (SYK) launch Mako Spine commercially in the US?
What applications does the new Mako 4 system support?
What is the current market status of Stryker's (SYK) Mako Shoulder application?
